The present results indicate that acetylation-dependent autophagic δ-catenin degradation by PCAF reduces oncogenic δ-catenin signaling, as indicated by E-cadherin processing and β-catenin-mediated signals, thereby inhibiting the progression of prostate cancer (Fig. S3). Here, KAT2B is linked to prostate carcinoma.